Brief: Enorama Pharma AB Q4 Operating Loss Up At Sek 2.4 Million
15/02/2018 06:36
Feb 15 (Reuters) - ENORAMA PHARMA AB ERMA.ST :
* Q4 OPERATING LOSS SEK 2.4 MILLION VERSUS LOSS SEK 1.9
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr5Px4tY
Further company coverage: ERMA.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO